Literature DB >> 25696066

The NVVC working group guidelines for the management of patients with non-ST-elevation acute coronary syndromes.

R J de Winter.   

Abstract

Entities:  

Year:  2002        PMID： 25696066      PMCID： PMC2499679     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  37 in total

1.  Risk stratification in acute coronary syndrome using cardiac troponin I.

Authors:  J Ravkilde
Journal:  Clin Chem       Date:  2000-04       Impact factor: 8.327

Review 2.  Evaluation of the patient with acute chest pain.

Authors:  T H Lee; L Goldman
Journal:  N Engl J Med       Date:  2000-04-20       Impact factor: 91.245

3.  Low-molecular weight heparin reduces the generation and activity of thrombin in unstable coronary artery disease.

Authors:  M Ernofsson; F Strekerud; H Toss; U Abildgaard; L Wallentin; A Siegbahn
Journal:  Thromb Haemost       Date:  1998-03       Impact factor: 5.249

4.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Authors:  C P Cannon; W S Weintraub; L A Demopoulos; R Vicari; M J Frey; N Lakkis; F J Neumann; D H Robertson; P T DeLucca; P M DiBattiste; C M Gibson; E Braunwald
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

5.  National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases.

Authors:  A H Wu; F S Apple; W B Gibler; R L Jesse; M M Warshaw; R Valdes
Journal:  Clin Chem       Date:  1999-07       Impact factor: 8.327

6.  Cardiac troponin T as a marker for myocardial ischemia in patients seen at the emergency department for acute chest pain.

Authors:  P A Johnson; L Goldman; D B Sacks; T Garcia; M Albano; M Bezai; A Pedan; E F Cook; T H Lee
Journal:  Am Heart J       Date:  1999-06       Impact factor: 4.749

7.  Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease.

Authors:  L Wallentin; B Lagerqvist; S Husted; F Kontny; E Ståhle; E Swahn
Journal:  Lancet       Date:  2000-07-01       Impact factor: 79.321

8.  Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis.

Authors:  J W Eikelboom; S S Anand; K Malmberg; J I Weitz; J S Ginsberg; S Yusuf
Journal:  Lancet       Date:  2000-06-03       Impact factor: 79.321

9.  Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.

Authors:  A S Go; E M Hylek; K A Phillips; L H Borowsky; L E Henault; Y Chang; J V Selby; D E Singer
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

10.  Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.

Authors:  E M Antman; M J Tanasijevic; B Thompson; M Schactman; C H McCabe; C P Cannon; G A Fischer; A Y Fung; C Thompson; D Wybenga; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-31       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.